Skip to NavigationSkip to content

Business Services

UCL: Lateral flow test more accurate than previously thought

Researchers from University College London (UCL) have been studying the accuracy of lateral flow tests (LFTs), and have found them to be far more accurate than previously thought, it was announced on Thursday.

The UCL peer-reviewed study concludes that criticism of LFTs for low sensitivity "have reached the wrong conclusions", "confused policy-making", and "damaged public trust in LFTs".

Women and children most impacted by mental health during pandemic

The Headway 2023 Mental Health Index has revealed that the pandemic has taken a significant toll on the mental health of women and children. 83% of women have reported that the pandemic negatively impacted their mental health compared to 36% of men.

The social isolation of lockdown, in conjunction with numerous other complexities caused by the pandemic, has exacerbated the issue of mental health throughout the UK. This has also disproportionately affected women, both at work and at home, and particularly women from minority ethnic groups.

Incyte trial reveals encouraging results for patients with vitiligo

Incyte has announced full results from its Phase III TRuE-V Program, evaluating Ruxolitinib Cream in patients with vitiligo. Treatment with Opzelura was found to result in facial repigmentation at week 24. A significant proportion of patients treated with ruxolitinib cream achieved a higher than 50% improvement from baseline in total body Vitiligo Area Scoring Index (T-VASI50).

Nobel Prize awarded to molecule construction champions

Benjamin List and David MacMillan have been awarded the Nobel prize in chemistry, for their construction of a tool used for building molecules. This tool has helped develop new drugs, bolstering the pharmaceutical industry considerably.

Professor List is a German scientist and Director of the Max Planck Institute for Coal Research, while Professor MacMillan is a US-based professor at Princeton University, US. Although the two worked independently of one another, they have been jointly awarded this prize.

Eli Lilly and India’s Cipla enter deal on diabetes treatments

Eli Lilly and Mumbai-based Cipla have announced a deal in which Cipla will sell and distribute two of Lilly’s best-selling diabetes treatments in India, the companies said in a joint statement on Monday.

Lilly will transfer its rights in India to sell, promote and distribute its Trulicity (dulaglutide) and Humalog (insulin lispro) products, while continuing to maintain its existing operating model for the remaining portfolio of its products.

EADV reveals vaccine hesitancy in psoriasis patients

Research presented at the European Academy of Dermatology and Venerology (EADV) 30th Congress has revealed that psoriasis and psoriatic arthritic patients are hesitant about receiving the COVID-19 vaccine, due to concerns about vaccine safety, and aggravation of their condition.

Nanoform granted funding to tackle global health challenges

Innovative nanoparticle medicine company, Nanoform, has announced that proof of concept studies will receive funding from the Bill & Melinda Gates Foundation. The aim of this funding is to assess the added value that Nanoform’s CESS® nanoparticle engineering technology can deliver to its drug development projects.

MSD pioneers gender-neutral HPV vaccine in India

MSD Pharmaceuticals has announced the launch of India’s first gender-neutral Human Papillomavirus (HPV) vaccine, according to ABP Live. The aim of the vaccine is to alleviate the burden of HPV-related disease in the country.

Driver shortages: UK pharmacies left in dark by government

Pharmacists in the UK have been left in the dark by the government, as they still don’t know what measures are to be taken to help deal with supply chain shortages caused by delivery driver shortages.

The National Pharmacists Association (NPA) said on Sunday that it was aware that deliveries to some pharmacies had been reduced and that its members worked together and with local GPs to get medicines that were needed when problems occurred.

Pfizer COVID-19 vaccine to be given to older and at-risk Americans

The FDA have approved a booster dose of the Pfizer BioNTech COVID-19 vaccine for those aged 65 and above, as well as for immunocompromised people aged 18 to 64 years. Millions of people who had their second dose of the vaccine at least six months ago will be able to receive their booster shot in the US this week.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches